Cytokine stimulation by Pseudomonas aeruginosa -strain variation and modulation by pulmonary surfactant

Experimental Lung Research

Volumn 30, Issue 3, 2004, Pages 163-179

  Bufler, Philip ^a   Schikor, Daniela ^a   Schmidt, Bettina ^a   Griese, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Innate immunity; P. aeruginosa; Surfactant lipids; Surfactant proteins A and D

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BERACTANT; CYTOKINE; LIPID; LUNG SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEROTYPE; STENOTROPHOMONAS MALTOPHILIA;

BACTERIAL ADHESION; CELL LINE; CYSTIC FIBROSIS; DOWN-REGULATION; HUMANS; LIPIDS; LIPOPOLYSACCHARIDES; MONOCYTES; PHOSPHOLIPIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642488971     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490276294     Document Type: Article

References (48)

1. DiMango E, Ramer AJ, Bryan R, Tabibi S, Prince A: Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest. 1998;101:2598-2605.
2. Ciacci-Woolwine F, McDermott PF, Mizel SB: Induction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes. Infect Immun. 1999;67:5176-5185.
3. Becker S, Fenton MJ, Soukup JM: Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Am J Respir Cell Mol Biol. 2002;27:611-618.
4. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, Miller SI: Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science. 1999;286:1561-1565.
5. Crouch E, Wright JR: Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol. 2001;63:521-554.
6. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S: Host defence capacities of pulmonary surfactant evidence for 'non-surfactant' functions of the surfactant system. Eur J Clin Invest. 1994;24:586-599.
7. Wright JR: Immunomodulatory functions of surfactant. Physiol Rev. 1997;77:931-962.
8. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR: Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 1998;19:700-708.
9. Restrepo CI, Qun D, Savov J, Mariencheck WI and Wright JR: Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol. 1999;21:576-585.
10. Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J. 1997;10:1983-1988.
11. Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO: Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol. 1999;20:90-98.
12. Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, Lewandoski J, Zimmerman JJ: Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest. 2000;118:164-174.
13. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S: Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995;152:1860-1866.
14. von Bredow C, Birrer P, Griese M: Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J. 2001;17:716-722.
15. Griese M, Wiesener A, Lottspeich F, and von Bredow C: Limited proteolysis of surfactant protein D causes a loss of its calcium-dependent lectin functions. Biochim Biophys Acta. 2003;1638:157-163.
16. Bufler P, Schmidt B, Schikor D, Bauernfeind A, Crouch EC, Griese M: Surfactant protein A and D differently regulate the immune response to P. aeruginosa and its lipopolysaccharide. Am J Resp Cell Mol Biol. 2003;28:249-256.
17. van Iwaarden JF, Pikaar JC, Storm J, Brouwer E, Verhoef J, Oosting RS, van Golde LMG, van Strijp JAG: Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J. 1994;303:407-411.
18. Stamme C, Muller M, Hamann L, Gutsmann T, Seydel U: Surfactant protein A inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein. Am J Respir Cell Mol Biol. 2002;27:353-360.
19. Kuan SF, Rust K, Crouch E: Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest. 1992;90:97-106.
20. Sahly H, Ofek I, Podschun R, Brade H, He Y, Ullmann U, Crouch E: Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich O-antigens. J Immunol. 2002;169:3267-3274.
21. Allen JN, Moore SA, Pope-Harman AL, Marsh CB, and Wewers MD: Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J Lab Clin Med. 1995;125:356-369.
22. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ: Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol. 1996;14:374-379.
23. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP: Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha type II receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res. 1998;44:32-36.
24. Speer CP, Gotze B, Curstedt T, Robertson B: Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res. 1991;30:69-74.
25. Talati AJ, Crouse DT, English BK, Newman C, Livingston L, Meals E: Exogenous bovine surfactant suppresses tumor necrosis factor-alpha release by murine macrophages stimulated by genital mycoplasmas. J Infect Dis. 1998;178:1122-1125.
26. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP: Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am J Respir Cell Mol Biol. 1994;10:399-404.
27. Manz KH, Egenhofer C, Plattner H, Schlepper SJ: Specific interaction of lung surfactant protein A (SP-A) with rat alveolar macrophages. Exp Cell Res. 1991;192:597-603.
28. Ross GF, Meuth J, Ohning B, Kim Y, Whitsett JA: Purification of canine surfactant-associated glycoproteins A. Identification of a collagenase- resistant domain. Biochim Biophys Acta. 1986;870:267-278.
29. Wright JR, Borchelt JD, Hawgood S: Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. Proc Natl Acad Sci U S A. 1989;86:5410-5414.
30. Golioto A, Wright JR: Effects of surfactant lipids and surfactant protein a on host defense functions of rat alveolar macrophages. Pediatr Res. 2002;51:220-227.
31. Kremlev SG, Phelps DS: Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol. 1994;267:1712-1719.
32. Kremlev SG, Umstead TM, Phelps DS: Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol. 1994;267:1357-1364.
33. Kremlev SG, Phelps DS: Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line. Am J Physiol. 1997;272:11070-11077.
34. Westphal O, Lüderitz O Bister F: Über die Extraktion von Bakterien mit Phenol-Wasser. Naturforsch. 1952;7:148-150.
35. Wallach D: Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J Immunol. 1984;132:2464-2469.
36. Finter NB: Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assay. J Gen Virol. 1969;5:419-427.
37. McNeely TB, Coonrod JD: Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol. 1994;11:114-122.
38. Tino MJ, Wright JR: Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol. 1996;270:1677-1688.
39. Goldberg JB, Pier GB: Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. Trends Microbiol. 1996;4:490-494.
40. Hickling TP, Sim RB, Malhotra R: Induction of TNF-alpha release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS Lett. 1998;437:65-69.
41. Koptides M, Umstead TM, Floros J, Phelps DS: Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am J Physiol. 1997;273:1382-1388.
42. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX: Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111:1589-1602.
43. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y: Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem. 2000;275:22442-22451.
44. Sano H, Sohma H, Muta T, Nomura S, Voelker DR, Kuroki Y: Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol. 1999;163:387-395.
45. Song M, Phelps DS: Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line. Infect Immun. 2000;68:6611-6617.
46. Augusto LA, Synguelakis M, Johansson J, Pedron T, Girard R, Chaby R: Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect Immun. 2003;71:61-67.
47. Kalina M, Blau H, Riklis S, Kravtsov V: Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am J Physiol. 1995;268:1144-1151.
48. Stamme C, Wright JR: Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages. Am J Physiol. 1999;276:1540-1547.